Astrazeneca Ab Performance

Astrazeneca Relative Risk vs. Return Landscape

If you would invest (100.00) in Astrazeneca Ab on September 12, 2024 and sell it today you would earn a total of  100.00  from holding Astrazeneca Ab or generate -100.0% return on investment over 90 days. Astrazeneca Ab is generating negative expected returns assuming volatility of 0.0% on return distribution over 90 days investment horizon. In other words, 0% of stocks are less volatile than Astrazeneca, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  

Astrazeneca Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Astrazeneca's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Astrazeneca Ab, and traders can use it to determine the average amount a Astrazeneca's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
AAB
Based on monthly moving average Astrazeneca is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Astrazeneca by adding Astrazeneca to a well-diversified portfolio.

Things to note about Astrazeneca Ab performance evaluation

Checking the ongoing alerts about Astrazeneca for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Astrazeneca Ab help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Astrazeneca Ab is not yet fully synchronised with the market data
Astrazeneca Ab has some characteristics of a very speculative penny stock
Evaluating Astrazeneca's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Astrazeneca's stock performance include:
  • Analyzing Astrazeneca's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Astrazeneca's stock is overvalued or undervalued compared to its peers.
  • Examining Astrazeneca's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Astrazeneca's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Astrazeneca's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Astrazeneca's stock. These opinions can provide insight into Astrazeneca's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Astrazeneca's stock performance is not an exact science, and many factors can impact Astrazeneca's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Consideration for investing in Astrazeneca Stock

If you are still planning to invest in Astrazeneca Ab check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Astrazeneca's history and understand the potential risks before investing.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities